• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Bullous Pemphigoid Is Associated With Broad Serum Metabolic Reprogramming

by
November 14, 2026
in Health
Reading Time: 3 mins read
0
Bullous Pemphigoid Is Associated With Broad Serum Metabolic Reprogramming

Bullous Pemphigoid Is Associated With Broad Serum Metabolic Reprogramming

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A comprehensive serum metabolomics study has revealed that bullous pemphigoid is associated with broad systemic metabolic reprogramming spanning energy metabolism, redox homeostasis, amino acid metabolism, and lipid signaling. Bullous pemphigoid is an autoimmune subepidermal blistering disease characterized by autoantibody-mediated inflammation, yet its broader systemic metabolic alterations have remained incompletely understood in clinical dermatology. To investigate these metabolic changes, a research team led by Jing Ni, Ying Zhu, Wei Bian, Hui Xiao, Ying Luo, Xiao-yao Song, and Zhi-qi Song conducted an untargeted metabolomic analysis comparing individuals with bullous pemphigoid to healthy control subjects. The peer-reviewed findings were published in Archives of Dermatological Research as part of volume 318.

To capture circulating molecular profiles across participants, the investigators performed metabolomic profiling of serum samples utilizing ultra-high-performance liquid chromatography coupled with high-resolution mass spectrometry. This high-resolution analytical workflow successfully detected a total of 4,288 metabolites across the patient and healthy control cohorts. When the team applied partial least squares-discriminant analysis to model the multidimensional metabolomic data, the score plots revealed a clear separation between the bullous pemphigoid cohort and the healthy controls. Further statistical evaluation showed that 452 of the 4,288 detected metabolites exhibited significant differential abundance between the two groups, confirming substantial divergence in circulating small-molecule concentrations between individuals affected by the autoimmune blistering disorder and healthy participants.

Classification of the 452 significantly altered metabolites showed that they were primarily distributed across four fundamental biochemical classes: carbohydrates, lipids, amino acids, and nucleotides. To understand how these altered molecules interact within biological systems, the researchers conducted pathway enrichment analysis. This computational evaluation identified coordinated perturbations across several major routes of central energy metabolism. Specifically, the analysis highlighted significant disruptions in glycolysis and gluconeogenesis, the pentose phosphate pathway, and the tricarboxylic acid cycle. Beyond primary carbohydrate and energy metabolism, pathway enrichment analysis revealed coordinated alterations in sulfur-containing amino acid metabolism, glutathione-related pathways involved in redox homeostasis, and broader enzymatic pathways governing systemic lipid remodeling.

To elucidate specific molecular interactions, the study incorporated network-level analysis, which demonstrated distinct directional patterns among the perturbed metabolic pathways. In the central energy pathways, network evaluation showed a decreased abundance of multiple metabolic intermediates within both glycolysis and the tricarboxylic acid cycle in patients with bullous pemphigoid. Concurrently, network-level analysis revealed broad structural remodeling across circulating lipid classes. These alterations prominently affected lysophospholipids, membrane phospholipids, and signaling networks associated with sphingolipids. Together, these coordinated findings demonstrate that systemic metabolic reprogramming in bullous pemphigoid involves widespread suppression of key energy intermediates alongside extensive modifications to cellular membrane architecture and bioactive lipid signaling cascades.

The researchers noted important limitations inherent to the study design, emphasizing that the work was conducted as an exploratory investigation and was constrained by the limited availability of detailed clinical covariates. Because of these factors, the authors cautioned that the observed associations between altered serum metabolites and bullous pemphigoid must be interpreted as hypothesis-generating rather than demonstrating causal mechanisms. Nonetheless, the investigation delivers a systematic serum metabolomic overview of the autoimmune condition and maps critical points of systemic metabolic disruption. By delineating specific perturbations in central energy pathways, redox homeostasis, and lipid signaling, the study establishes an evidence-based set of candidate metabolic pathways to direct future mechanistic investigations and prospective biomarker-validation studies.

Subject of Research: Serum metabolomic alterations in bullous pemphigoid

Article Title: Serum metabolomics reveals systemic metabolic reprogramming associated with bullous pemphigoid

Article References: Ni, J., Zhu, Y., Bian, W., Xiao, H., Luo, Y., Song, X.-Y., & Song, Z.-Q. (2026). Serum metabolomics reveals systemic metabolic reprogramming associated with bullous pemphigoid. Archives of Dermatological Research, 318(1), Article 566. https://doi.org/10.1007/s00403-026-05006-7

Image Credits: AI Generated

DOI: 10.1007/s00403-026-05006-7

Keywords: bullous pemphigoid, serum metabolomics, metabolic reprogramming, high-resolution mass spectrometry, liquid chromatography, glycolysis, tricarboxylic acid cycle, pentose phosphate pathway, lipid remodeling, lysophospholipids, membrane phospholipids, sphingolipid signaling, sulfur-containing amino acids, glutathione metabolism, redox homeostasis, partial least squares discriminant analysis, energy metabolism, autoimmune blistering disease

News Source: Ophelia Keating. (November 14, 2026). Bullous Pemphigoid Is Associated With Broad Serum Metabolic Reprogramming. Scienmag.

Tags: autoimmune blistering diseasebullous pemphigoidEnergy metabolismglutathione metabolismglycolysishigh-resolution mass spectrometrylipid remodelingliquid chromatographylysophospholipidsmembrane phospholipidsMetabolic Reprogrammingpartial least squares discriminant analysispentose phosphate pathwayredox homeostasisserum metabolomicssphingolipid signalingsulfur-containing amino acidstricarboxylic acid cycle
Share12Tweet7Share2ShareShareShare1

Related Posts

Bacterial Messenger Cyclic di-AMP Enhances Staphylococcus aureus Virulence by Targeting SarS

Bacterial Messenger Cyclic di-AMP Enhances Staphylococcus aureus Virulence by Targeting SarS

November 17, 2026
Staged Bone Grafting and Nerve Repositioning Support Mandibular Implants in Case Report

Staged Bone Grafting and Nerve Repositioning Support Mandibular Implants in Case Report

November 17, 2026

Machine Learning Diagnostic Tools for Infections Lack Universal Performance Standards

November 17, 2026

Researchers Propose Clinical Decision Framework for Biomarker-Guided Acupuncture in Integrative Psychiatry

November 17, 2026

POPULAR NEWS

  • City of Hope, Adagene Launch Trial Testing Combination Immunotherapy for Colorectal Cancer

    City of Hope, Adagene Launch Trial Testing Combination Immunotherapy for Colorectal Cancer

    29 shares
    Share 12 Tweet 7
  • Repetitive Mild Brain Injury Triggers Chronic Cerebrovascular Inflammation and Glymphatic Suppression

    29 shares
    Share 12 Tweet 7
  • Durable Remission in Advanced Squamous-Cell Lung Cancer Following Sodium Selenite Treatment

    29 shares
    Share 12 Tweet 7
  • Circulating tRNA Fragments Distinguish Endometriosis Patients in Preliminary Pilot Study

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Bacterial Messenger Cyclic di-AMP Enhances Staphylococcus aureus Virulence by Targeting SarS

Acoustic Emissions Reveal Sliding Precursors in Red Sandstone Weak Interlayers

Trehalose Osmosis Improves Flavor Retention and Structural Stability in Jackfruit Powder

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.